Hangjun Zhan

Hangjun Zhan

Health Technology
Consumer Services

Profilo

Dr. Hangjun Zhan is a Chief Technology Officer at Attovia Therapeutics, Inc. He is on the Board of Directors at Vetmab Biosciences, Inc. Dr. Zhan was previously employed as a Chief Scientific Officer by Alamar Biosciences, Inc., a Chief Scientific Officer by Kindred Biosciences, Inc., a Member-Management Board by Aragen Bioscience, Inc., and a Head-Protein Biochemistry Team by Exelixis, Inc. He received his undergraduate degree from Zhejiang University and a doctorate degree from the University of Washington.

Posizioni attive di Hangjun Zhan

SocietàPosizioneInizio
ATTOVIA THERAPEUTICS, INC. Fondatore 16/12/2022
Fondatore -

Precedenti posizioni note di Hangjun Zhan

SocietàPosizioneFine
Direttore Tecnico/Scientifico/R&S 01/06/2023
KINDRED BIOSCIENCES, INC. Direttore Tecnico/Scientifico/R&S 01/06/2021
Corporate Officer/Principal 01/02/2014
EXELIXIS, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Hangjun Zhan

Formazione di Hangjun Zhan

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

99

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Hangjun Zhan